Medical Genetics

The Smith-Lemli-Opitz Syndrome (SLOS) Resource Guide

At a Glance

Smith-Lemli-Opitz Syndrome (SLOS) is a rare genetic disorder that impairs cholesterol production, affecting early development and multiple body systems. Diagnosis requires specialized sterol profiling, and lifelong treatment involves cholesterol supplementation and multidisciplinary care.

Welcome to the Smith-Lemli-Opitz Syndrome (SLOS) Resource Guide. Whether you are a parent receiving a new diagnosis for your child, or an adult who has recently been diagnosed with a milder form of the condition, this guide is designed to empower you with accurate, actionable information.

Smith-Lemli-Opitz Syndrome is a rare genetic disorder that affects how the body produces cholesterol. Because cholesterol is vital for early development and everyday bodily functions, a deficiency—combined with the buildup of toxic precursors—can affect nearly every system in the body ^[1]^[2].

This guide translates complex medical research into plain language to help you understand the condition, navigate the healthcare system, and advocate for the best possible care.

Explore the Guide

Please use the following links to explore the detailed resources in this guide:

Understanding Smith-Lemli-Opitz Syndrome: The First Steps

Learn the facts about Smith-Lemli-Opitz Syndrome (SLOS), a genetic disorder affecting cholesterol. Understand the DHCR7 gene, symptoms, and care steps.

The Wide Spectrum of Symptoms and Variability in SLOS

Discover the wide spectrum of Smith-Lemli-Opitz Syndrome (SLOS) symptoms. Learn about physical features, behavioral challenges, and disease severity.

Diagnosing SLOS: Lab Tests and Genetics

Learn how Smith-Lemli-Opitz syndrome is diagnosed. Understand sterol profiling for 7-DHC, standard vs. advanced lab tests, and DHCR7 genetic testing.

Management and Treatment Strategies for SLOS

Learn about Smith-Lemli-Opitz syndrome (SLOS) treatment and management. Discover how cholesterol supplementation, simvastatin, and sick-day plans can help.

Building Your Care Team: Essential Specialists for SLOS

Learn how to build a multidisciplinary care team for Smith-Lemli-Opitz Syndrome (SLOS). Understand the vital roles of geneticists and other key specialists.

Survivorship and the Long-Term Journey with SLOS

Learn about long-term survivorship with Smith-Lemli-Opitz Syndrome (SLOS). Understand adult care transition, lifelong surveillance, and managing symptoms.

Remember, while SLOS is a complex and lifelong condition, proactive management and a multidisciplinary care team can significantly improve quality of life and outcomes ^[3]^[4].

Common questions in this guide

What is Smith-Lemli-Opitz Syndrome (SLOS)?

Smith-Lemli-Opitz Syndrome is a rare genetic condition that prevents the body from producing enough cholesterol. Because cholesterol is essential for healthy development and daily functioning, this deficiency and the buildup of toxic precursors can impact nearly every system in the body.

How is SLOS diagnosed?

Standard cholesterol tests are usually not enough to diagnose SLOS. Doctors use specialized laboratory tests called sterol profiling, along with genetic testing, to confirm the diagnosis and understand the severity of the condition.

What are the standard treatments for SLOS?

Treatment typically involves dietary cholesterol supplementation and specific medications, such as simvastatin, to manage the body's cholesterol levels. Because SLOS affects multiple body systems, patients also need proactive emergency planning and a coordinated team of specialists.

What should be my first step after a new SLOS diagnosis?

Your most immediate priority should be asking for a referral to a comprehensive rare disease or metabolic clinic. Building a care team with specialized experience early on is crucial for managing the complex, long-term needs of SLOS.

Curated prompts to bring to your next appointment.

1.What is the most immediate priority for managing this diagnosis?
2.Can you provide a referral to a comprehensive rare disease or metabolic clinic?
3.Are there any patient registries or advocacy groups you recommend joining?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (4)

1
Smith-Lemli-Opitz syndrome: A pathophysiological manifestation of the Bloch hypothesis.
Chattopadhyay A, Sharma A
Frontiers in molecular biosciences 2023; (10()):1120373 doi:10.3389/fmolb.2023.1120373.
PMID: 36714259
2
The role of cholesterol biosynthesis and metabolism causing medical complexity in patients with Smith-Lemli-Opitz Syndrome (SLOS).
Elias ER
The Journal of steroid biochemistry and molecular biology 2025; (254()):106822 doi:10.1016/j.jsbmb.2025.106822.
PMID: 40609800
3
Smith-Lemli-Opitz Syndrome (SLOS)-Case Description and the Impact of Therapeutic Interventions on Psychomotor Development.
Kozera N, Śmigiel R, Rozensztrauch A
Journal of clinical medicine 2025; (14(23)) doi:10.3390/jcm14238569.
PMID: 41375871
4
First documented case of Smith-Lemli-Opitz syndrome in Syria: clinical presentation, diagnosis, and experimental management with simvastatin.
Aladia AH, Hamdan S, Alkheder A
Oxford medical case reports 2024; (2024(11)):omae129 doi:10.1093/omcr/omae129.
PMID: 39575090

This guide provides educational information about Smith-Lemli-Opitz Syndrome (SLOS) and is for informational purposes only. It does not replace professional medical advice, diagnosis, or treatment from your specialized metabolic or genetic care team.

Get notified when new evidence is published on Smith-Lemli-Opitz syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents